Medicamen Biotech Statistics

Total Valuation

NSE:MEDICAMEQ has a market cap or net worth of INR 5.39 billion. The enterprise value is 5.69 billion.

Market Cap	5.39B
Enterprise Value	5.69B

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	Sep 19, 2024

Share Statistics

Current Share Class	12.71M
Shares Outstanding	n/a
Shares Change (YoY)	+0.44%
Shares Change (QoQ)	-15.83%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.96M

Valuation Ratios

The trailing PE ratio is 75.84.

PE Ratio	75.84
Forward PE	n/a
PS Ratio	3.32
PB Ratio	2.53
P/TBV Ratio	2.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 41.00, with an EV/FCF ratio of -61.36.

EV / Earnings	79.99
EV / Sales	3.50
EV / EBITDA	41.00
EV / EBIT	83.71
EV / FCF	-61.36

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.16.

Current Ratio	2.11
Quick Ratio	0.93
Debt / Equity	0.16
Debt / EBITDA	2.40
Debt / FCF	-3.59
Interest Coverage	2.15

Financial Efficiency

Return on equity (ROE) is 3.12% and return on invested capital (ROIC) is 1.75%.

Return on Equity (ROE)	3.12%
Return on Assets (ROA)	1.44%
Return on Invested Capital (ROIC)	1.75%
Return on Capital Employed (ROCE)	3.11%
Revenue Per Employee	4.30M
Profits Per Employee	188,048
Employee Count	378
Asset Turnover	0.55
Inventory Turnover	1.39

Taxes

In the past 12 months, NSE:MEDICAMEQ has paid 33.24 million in taxes.

Income Tax	33.24M
Effective Tax Rate	33.65%

Stock Price Statistics

The stock price has decreased by -10.10% in the last 52 weeks. The beta is 1.03, so NSE:MEDICAMEQ's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-10.10%
50-Day Moving Average	432.23
200-Day Moving Average	480.65
Relative Strength Index (RSI)	52.06
Average Volume (20 Days)	34,171

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MEDICAMEQ had revenue of INR 1.63 billion and earned 71.08 million in profits. Earnings per share was 5.59.

Revenue	1.63B
Gross Profit	779.29M
Operating Income	67.92M
Pretax Income	98.80M
Net Income	71.08M
EBITDA	138.68M
EBIT	67.92M
Earnings Per Share (EPS)	5.59

Full Income Statement

Balance Sheet

The company has 37.59 million in cash and 332.53 million in debt, giving a net cash position of -294.94 million.

Cash & Cash Equivalents	37.59M
Total Debt	332.53M
Net Cash	-294.94M
Net Cash Per Share	n/a
Equity (Book Value)	2.13B
Book Value Per Share	167.35
Working Capital	863.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -71.94 million and capital expenditures -20.73 million, giving a free cash flow of -92.67 million.

Operating Cash Flow	-71.94M
Capital Expenditures	-20.73M
Free Cash Flow	-92.67M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 47.94%, with operating and profit margins of 4.18% and 4.37%.

Gross Margin	47.94%
Operating Margin	4.18%
Pretax Margin	6.08%
Profit Margin	4.37%
EBITDA Margin	8.53%
EBIT Margin	4.18%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.24%.

Dividend Per Share	1.00
Dividend Yield	0.24%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	17.89%
Buyback Yield	-0.44%
Shareholder Yield	-0.20%
Earnings Yield	1.32%
FCF Yield	-1.72%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4